Literature DB >> 17286727

A novel method for evaluation of improved survival trend for common cancer: early detection or improvement of medical care.

Wei-Chu Chie1, Yi-Hsin Chang, Hsiu-Hsi Chen.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: The improvement of survival with time for cancers has been observed worldwide. However, whether and to what extent such an improvement is attributed to early detection or the advance in medical technology is barely addressed.
METHOD: We developed a novel graphic method to calculate attributable proportions related to two factors. This graphic method was first to calculate adjusted survival curve by the application of direct standardized epidemiological method to tumour staging. The crude survival curve was then compared with the adjusted survival curve.
RESULTS: Cumulative survival curves of two time epochs, 1989-1993 (period 1) and 1994-1998 (period 2), on six common cancers collected from cancer registry of National Taiwan University between 1989 and 1998, were compared. The attributable proportions due to early detection and medical care were 77% and 23% for breast cancer, 50% and 50% for cervical cancer, 52% and 48% for colorectal cancer, 76% and 24% for gastric cancer, 66% and 34% for liver cancer, and 30% and 70% for prostate cancer respectively.
CONCLUSION: Distinguishing between early detection from advance in medical care associated with the improvement of survival trend using our graphic method has a significant implication for secondary and tertiary prevention of common cancers.

Entities:  

Mesh:

Year:  2007        PMID: 17286727     DOI: 10.1111/j.1365-2753.2006.00656.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  3 in total

Review 1.  Role of surveillance in prevention of hepatocellular carcinoma.

Authors:  Dipanjan Panda
Journal:  J Clin Exp Hepatol       Date:  2014-05-25

2.  DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.

Authors:  Marie Loh; Natalia Liem; Aparna Vaithilingam; Pei Li Lim; Nur Sabrina Sapari; Eiram Elahi; Zuan Yu Mok; Chee Leong Cheng; Benedict Yan; Brendan Pang; Manuel Salto-Tellez; Wei Peng Yong; Barry Iacopetta; Richie Soong
Journal:  BMC Gastroenterol       Date:  2014-03-28       Impact factor: 3.067

3.  The Role of MMP8 in Cancer: A Systematic Review.

Authors:  Krista Juurikka; Georgina S Butler; Tuula Salo; Pia Nyberg; Pirjo Åström
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.